Ignite Creation Date:
2025-12-25 @ 2:24 AM
Ignite Modification Date:
2026-04-19 @ 9:16 AM
Study NCT ID:
NCT02254434
Status:
COMPLETED
Last Update Posted:
2017-11-13
First Post:
2014-09-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Pharmacokinetic Study of Eltrombopag 50 Milligram (mg) in Healthy Volunteers Under Fasting Conditions
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-08-28
Start Date Type:
ACTUAL
Primary Completion Date:
2014-09-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-09-08
Completion Date Type:
ACTUAL
First Submit Date:
2014-09-29
First Submit QC Date:
None
Study First Post Date:
2014-10-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-11-08
Last Update Post Date:
2017-11-13
Last Update Post Date Type:
ACTUAL